StockData
Haemonetics Corp logo

Haemonetics Corp (HAE) stock

HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q1 FY2027, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3073% above fair value
$120.92−0.42 (-0.35%)

Close on Nov 17, 2026Market cap $5.50BP/E 59.0Yield –

Haemonetics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Haemonetics's operating cash flow for the twelve months ending Jun 27, 2026 was $328.15M, up 44.9% year over year. For fiscal 2026 it was $293.22M, up 61.4% from the year before. Over ten years it grew 9.2% a year on average. The highest annual figure on record is $293.22M in fiscal 2026.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Mar 28, 2026$293.22M+61.4%
FY2025Mar 29, 2025$181.73M-0.0%
FY2024Mar 30, 2024$181.75M-33.4%
FY2023Apr 1, 2023$273.06M+58.5%
FY2022Apr 2, 2022$172.26M+58.3%
FY2021Apr 3, 2021$108.81M-31.2%
FY2020Mar 28, 2020$158.22M-0.7%
FY2019Mar 30, 2019$159.28M-27.7%
FY2018Mar 31, 2018$220.35M+37.9%
FY2017Apr 1, 2017$159.74M+31.1%
FY2016Apr 2, 2016$121.87M-4.2%
FY2015Mar 28, 2015$127.18M-8.8%
FY2014Mar 29, 2014$139.52M+64.0%
FY2013Mar 30, 2013$85.07M-26.2%
FY2012Mar 31, 2012$115.32M-6.6%
FY2011Apr 2, 2011$123.46M-5.5%
FY2010Apr 3, 2010$130.67M+12.3%
FY2009Mar 28, 2009$116.36M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 27, 2026$52.32M+200.8%
Q4 FY2026CQ1 2026Mar 28, 2026$70.94M-39.1%
Q3 FY2026CQ4 2025Dec 27, 2025$93.56M+113.8%
Q2 FY2026CQ3 2025Sep 27, 2025$111.32M+128.0%
Q1 FY2026CQ2 2025Jun 28, 2025$17.40M–
Q4 FY2025CQ1 2025Mar 29, 2025$116.56M+81.9%
Q3 FY2025CQ4 2024Dec 28, 2024$43.77M–
Q2 FY2025CQ3 2024Sep 28, 2024$48.82M-50.7%
Q1 FY2025CQ2 2024Jun 29, 2024-$27.42M-243.7%
Q4 FY2024CQ1 2024Mar 30, 2024$64.08M-19.5%
Q3 FY2024CQ4 2023Dec 30, 2023-$540.00K-100.8%
Q2 FY2024CQ3 2023Sep 30, 2023$99.12M+13.9%
Q1 FY2024CQ2 2023Jul 1, 2023$19.09M-54.5%
Q4 FY2023CQ1 2023Apr 1, 2023$79.61M+17.0%
Q3 FY2023CQ4 2022Dec 31, 2022$64.42M+3.2%
Q2 FY2023CQ3 2022Oct 1, 2022$87.04M+100.3%
Q1 FY2023CQ2 2022Jul 2, 2022$41.99M–
Q4 FY2022CQ1 2022Apr 2, 2022$68.05M+4298.8%
Q3 FY2022CQ4 2021Jan 1, 2022$62.43M-5.8%
Q2 FY2022CQ3 2021Oct 2, 2021$43.46M+49.1%
Q1 FY2022CQ2 2021Jul 3, 2021-$1.68M-114.2%
Q4 FY2021CQ1 2021Apr 3, 2021$1.55M-96.7%
Q3 FY2021CQ4 2020Dec 26, 2020$66.29M-16.4%
Q2 FY2021CQ3 2020Sep 26, 2020$29.16M-2.5%
Q1 FY2021CQ2 2020Jun 27, 2020$11.81M+349.5%
Q4 FY2020CQ1 2020Mar 28, 2020$46.41M+124.9%
Q3 FY2020CQ4 2019Dec 28, 2019$79.28M+36.3%
Q2 FY2020CQ3 2019Sep 28, 2019$29.90M-47.9%
Q1 FY2020CQ2 2019Jun 29, 2019$2.63M-88.6%
Q4 FY2019CQ1 2019Mar 30, 2019$20.64M-64.2%
Q3 FY2019CQ4 2018Dec 29, 2018$58.16M-11.1%
Q2 FY2019CQ3 2018Sep 29, 2018$57.36M-2.6%
Q1 FY2019CQ2 2018Jun 30, 2018$23.12M-39.8%
Q4 FY2018CQ1 2018Mar 31, 2018$57.63M+66.7%
Q3 FY2018CQ4 2017Dec 30, 2017$65.40M+18.5%
Q2 FY2018CQ3 2017Sep 30, 2017$58.90M+50.0%
Q1 FY2018CQ2 2017Jul 1, 2017$38.43M–
Q4 FY2017CQ1 2017Apr 1, 2017$34.58M–
Q3 FY2017CQ4 2016Dec 31, 2016$55.20M–
Q2 FY2017CQ3 2016Oct 1, 2016$39.27M–

More Haemonetics figures

See a number that looks wrong?